The new owners of a Waltham lab complex obtained first mortgage financing from Wells Fargo for the acquisition.

A $74.2 million mortgage was taken out for the 182,104-square-foot complex on 830 Winter St. in Waltham.

Cambridge-based King Street Properties and Carlyle Realty Partners VII LP jointly acquired 830 Winter St. from Boston-based Intercontinental Real Estate Corp. in August for $104.2 million, or $572 per square foot.

HFF’s debt placement team led by Greg Labine worked on behalf of the borrower to obtain the floating-rate loan from Wells Fargo.

Completed in 2001 as the headquarters for Praecis Pharmaceuticals, the property is currently fully leased to ImmunoGen, GlaxoSmithKline and Histogenics Corp.

“As is the case with many acquisitions in the current market environment, the financing had to be obtained quickly to hit the tight closing timeframe. HFF, along with a tremendous effort by the Wells Fargo team, was able to close the deal within 54 days of our initial engagement,” LaBine said in a statement.

Intercontinental purchased the building in 2005 in a partial sale-leaseback to Praecis Pharmaceuticals. On-site amenities include a full-service cafeteria, outside seating, conference facilities and structured parking.